MUVON Therapeutics Company
MUVON Therapeutics is a biotech company that aims to develop and market a new therapy for the regeneration of skeletal muscle tissue using autologous cells. Their primary focus is on developing a safe and effective treatment for stress urinary incontinence in women. The company can be contacted through mail, phone, and physical address.
Headquarters:
Zurich, Switzerland
Employee Number:
11-50
Founded Date:
29.10.2020
Estimated Revenue:
$3.3MMuvon Therapeutics
Industry:
Longevity
Funding Status:
Start-up